US 10703797
Gene therapy vectors for treatment of Danon disease
granted A61KA61K38/00A61K38/177
Quick answer
US patent 10703797 (Gene therapy vectors for treatment of Danon disease) held by Rocket Pharmaceuticals, Ltd. expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rocket Pharmaceuticals, Ltd.
- Grant date
- Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K38/177, A61K48/00, A61K48/0066